[Prenatal diagnosis and genetic counseling in two pedigrees affected with infantile polycystic kidney disease due to PKHD1 gene mutations]

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019 Aug 10;36(8):765-768. doi: 10.3760/cma.j.issn.1003-9406.2019.08.003.
[Article in Chinese]

Abstract

Objective: To detect potential mutations of the PKHD1 gene in two pedigrees affected with infantile polycystic kidney disease.

Methods: Clinical data and peripheral venous blood samples were collected from the probands and their parents as well as fetal amniotic fluid cells. Genome DNA was extracted from the peripheral blood samples and amniotic fluid cells. Exons 32 and 61 of the PKHD1 gene were amplified with PCR and subjected to direct sequencing.

Results: The proband of pedigree 1 was found to carry c.4274T>G (p.Leu1425Arg) mutation in exon 32 and c.10445G>C (p.Arg3482Pro) mutation in exon 61 of the PKHD1 gene, which were inherited from her father and mother, respectively. The fetus has carried the c.4274T>G (p.Leu1425Arg) mutation. In pedigree 2, the wife and her husband had respectively carried a heterozygous c.5979_5981delTGG mutation and a c.9455delA mutation of the PKHD1 gene. No chromosomal aberration was found in the umbilical blood sample, but the genetic testing of their fetus was failed. Based on software prediction, all of the 4 mutations were predicted to be pathogenic.

Conclusion: PKHD1 c.4274T>G (p.Leu1425Arg), c.10445G>C (p.Arg3482Pro), c.5979_5981delTGG and c.9455delA were likely to be pathogenic mutations. The results have facilitated genetic counseling and prenatal diagnosis for the two pedigrees.

MeSH terms

  • DNA Mutational Analysis
  • Female
  • Genetic Counseling*
  • Humans
  • Mutation
  • Pedigree
  • Polycystic Kidney Diseases / diagnosis*
  • Polycystic Kidney Diseases / genetics*
  • Pregnancy
  • Prenatal Diagnosis*
  • Receptors, Cell Surface / drug effects*

Substances

  • PKHD1 protein, human
  • Receptors, Cell Surface